Filing Details
- Accession Number:
- 0001628908-17-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-14 17:32:11
- Reporting Period:
- 2017-06-12
- Filing Date:
- 2017-06-14
- Accepted Time:
- 2017-06-14 17:32:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1628908 | Evolent Health Inc. | EVH | Services-Management Services (8741) | 320454912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643086 | Nicholas Mcgrane | C/O Evolent Health, Inc. 800 N. Glebe Road, Suite 500 Arlington VA 22203 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2017-06-12 | 1,667 | $3.84 | 33,256 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2017-06-12 | 1,567 | $24.53 | 31,689 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2017-06-12 | 100 | $25.40 | 31,589 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Class A Common Stock Option (right to buy) | Disposition | 2017-06-12 | 1,667 | $0.00 | 1,667 | $3.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 211,285 | 2024-10-22 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.
- Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- The price reported on Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $24.05-$24.85, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Class A Common Stock Options exercised vested on February 1, 2016.
Billionaire Hedge Funds
